Skip to main content
. Author manuscript; available in PMC: 2013 Aug 29.
Published in final edited form as: Breast Cancer Res Treat. 2010 Oct 26;125(1):137–143. doi: 10.1007/s10549-010-1226-z

Table 2.

Response to therapy

Best response status N (%)
Clinical benefit (CB)a 8 (23)
Partial response (PR) 1 (3)
Stable disease ≥24 weeks (SD) 7 (20)
Progressive disease (PD) 14 (40)
Off study without confirmation of CB or PD 13 (37)
a

CB was defined as patients with complete response (CR), partial response (PR) or stable disease (SD) for ≥24 weeks